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ABSTRACT 
Objective: To describe a case of a child with IncontinentiaPigmenti associated with precocious 
puberty. Case description: a 1 year 7 months old female babywas taken by her parents to a 
medical appointment because of an aggravation of skin spots with a latté color disseminated 
throughout the body, which appeared when the child was five months old. The mother also 
referred premature thelarche and premature pubarche since the child was three months old. 
Comments: Precocious puberty is defined as the development of secondary sexual 
characteristics before the age of eightin girls and nine in boys. The Bloch-Sulzberger syndrome, 
or Incontinentia Pigmenti, is a disorder linked to the X chromosome that affects the skin, eyes, 
teeth and may be associated with neurological deficits. As much as this specific syndrome 
involves multiple organs and systems, there was no association with an endocrine disorder.  
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RESUMO 
 
Objetivo: Descrever o caso de uma criança com Incontinência  pigmentar associada à 
puberdade precoce. Descrição do caso: uma criança do sexo feminino de 1 ano e 7 
mesesfoilevadapelosseuspaisaumaconsultamédicadevidoaoagravamento de lesões 
cutâneas de coloração marrom, disseminadas por todo o corpo, que surgiram quando a 
criança possuía cinco meses de vida. A mãe também queixou de telarca e pubarca 
precoces, presentes desde os três meses de vida. Comentários: Puberdade precoce é 
definida como o desenvolvimento de características sexuais secundárias antes dos oito 
anos em meninas, ou antes dos nove anos de idade nos meninos. Já a Síndrome de 
Bloch-Sulzberger, ou Incontinência Pigmentar, é uma desordem ligada ao cromossomo 
X que afeta a pele, os olhos, os dentes e pode estar associada a déficits neurológicos. 
Por mais que essa síndrome específica envolva múltiplos órgãos e sistemas, não há 
associação com um distúrbio endócrino.  
Palavras-chave: Puberdade precoce; Síndrome de Bloch-Sulzberger; Incontinência 
Pigmentar. 
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INTRODUCTION 
 
Puberty is the biological maturation 
process that, through hormonal changes, 
culminates in the appearance of secondary 
sexual characteristics, speeding up the 
growth rate and, finally, the acquisition of 
reproductive capacity of adult life¹. 
Precocious puberty (PP) is defined 
as the development of secondary sexual 
characteristics before the age of eight in 
girls and age nine in boys. It is classified as 
central PP, when the sexual characteristics 
develop by precocious activation of the 
hypothalamic-pituitary-gonadal axis (HPG) 
or peripheral PP, when the steroids 
secretion occurs independently of the 
secretion of gonadotropins LH (luteinizing 
hormone) and FSH (hormone follicle 
stimulating)². It is a rare condition, with an 
estimated incidence of 1:5,000-1:10,000
3
, 
more common in girls, and in 80% of 
central PP cases, the etiology is idiopathic². 
The Bloch-Sulzberger Syndrome 
or, IncontinentiaPigmenti (IP), is a 
dominant ectodermal disorder linked to the 
X chromosome. It affects the skin, eyes, 
teeth and may be associated with 
neurological deficits. It has an approximate 
incidence of 1: 50,000 and it is typically 
lethal in males
4
. In 50% of the cases, there 
is a family history. Recently, the IP´s 
causewas attributed to a mutation that 
inactivates the NEMO gene located on the 
X chromosome (q28). The cutaneous 
presentation of IP regressesspontaneously 
by selective elimination of the cells 
presenting mutant X-chromosome, with 
gradual replacement by normal 
cells
5
. Usually, dermatological findings are 
the first sign observed
4,5
. 
 
CASE REPORT 
 
C. P. M, female, 1 year 7 months 
old baby was taken by her parents to a 
medical appointment with an endocrine-
pediatrician. The mother reported 
anaggravation of skin spots with alatté 
color, brindle aspect, disseminated 
throughout the body, which appeared when 
the child was five months old. The mother 
also referred premature thelarche and 
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premature pubarche sincethe child was 
three months old. 
In the past obstetric history of the 
mother, there wasan adequate prenatal care 
and no gestational pathologies. The child 
was the first one, born by natural vaginal 
delivery, at term, without complications, 
and with an appropriate weight and height 
at birth. The child had no associated 
diseases or past trauma, having only one 
ulnar fracture when she was nine months 
old. In addition, there was no evidence of 
medication use. The parents were healthy 
and the mother reported menarche at the 
age of 14. In anthropometry, the mother´s 
height was 1.70 m high, the father height 
was 1.83 m high and the child target height 
was 1.70 m high, with a standard deviation 
of + or - 8 cm. 
In clinical examination, it was 
seendiffuse light brown colored 
swirlinghyper pigmentation in the child 
body (Figure 1). The child had a weight of 
13.200 kg (p 75) and the height of 89 cm 
(above p 97.5). In relation to pubertal 
development, according to the Tanner 
stages, the child was M1 P2. The palpation 
of the thyroid gland revealed no 
abnormalities. 
 
Figure 1: 5 yearsoldchild. Light 
browncoloredswirlinghyperpigmentationtip
icalofIncontinentiaPigmenti –thirdstage. 
The mother had exams of when the 
child was eight months old, which were: 
1)left hand and wrist X-ray,evaluated by the 
Greulich– Pyle methods, who revealed bone 
age of two years old; 2) a normal bone 
scan; 3) a normal cortrosynstimulation test; 
4) an abdominal ultrasound revealing an 
infantileuterus and ovaries; 5) LH = 0.43 
mIU/ml; FSH: 6.58 mIU/mL (prepubertal 
values); and normal values of adrenal 
hormones. 
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Because of these results, we 
requested aGnRH stimulation test (75 
mcg/m2)anda new left hand and wrist X-
ray. A month and a half laterthe mother 
returned with the tests results, which 
showed a bone age of three years old (when 
chronologically the child was 1 year 8 
months old); LH peak of 13.3 U/Land FSH 
peak of 55.2 U/L. In the new 
anthropometric examination, the results 
showed that the child had a hight of 90,5 
cm, demonstrating a growth velocity (GV) 
of 9 cm/year evaluated in the period of a 
month and a half. Estradiol 
(Chemiluminescence) was below 20, 
showing infantile ovaries. The child was 
diagnosed with precocious puberty and it 
was decided to start drug treatment due to 
the target height loss. 
At the age of two, the child began 
treatment with Leuprolide acetate 3.75 mg 
IM every 28 days.Itwas also recommended 
a dermatology appointment for elucidation 
of skin lesions. 
In appointment with the 
dermatologist, the childwas diagnosed with 
Bloch-Sulzberger Syndrome 
(IncontinentiaPigmenti), which was later 
confirmed by histopathological analysis of 
biopsied skin. It is a genetic syndrome, X-
linked, whose availablemedical 
management is based purely on clinical 
follow-up. Therefore, itwasrecommended 
that a neurologist and an ophthalmologist 
should evaluate the childfor diagnosis and 
monitoring of possible changes 
resultedfrom the syndrome itself. The first 
doctor requested a Magnetic Resonance 
Imaging (MRI) of the brain, which showed 
mild ectasia of the lateral ventricles and the 
fourth ventricle. Nevertheless, according to 
the evaluation of the doctor, the child 
showed no cognitive or neurological 
deficits. In relation to ocular changes, there 
was a refractive disorder (astigmatism) and 
keratitis, both were being treated by the 
responsible doctor. 
After two years of treatment for 
precocious puberty, at  the age of3 years 
and 10 months old, the child was in good 
physical development, which was proved 
by the fact that she had achieved adequate 
weight and height for the age (Weight: 
22.500 kg; Height: 112, 5 cm). Therewas a 
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bone age progression (bone age of 6 years 
old), however, with recovery of the target 
height. In this period, new laboratory tests 
showed suppressed dosages of FSH and 
LH. Currently, the child remains under care 
with endocrine-pediatrician. 
 
DISCUSSION  
 
The Bloch-Sulzberger syndrome 
presents a nonspecific histological 
characteristic where there isa melanin 
incontinence on melanocytes of the basal 
layer in the superficial dermis
5
. In 90% of 
cases, in the first two weeks of life, the skin 
lesions appear and are characterized by four 
stages (4,5), which may occur concurrently 
or sequentially: 1) vesicular (blisters and 
vesicles located in the limbs, scalp and, 
sometimes,on trunk; 2) hyperkeratotic 
(linear hyperkeratotic plaques); 3) 
hyperpigmented (brownish pigmentation 
following the Blashko’s lines); 4) atrophic 
(skin atrophy zones)
6-9
. The child presented 
itself in the third stage, with light 
browncoloredswirlinghyperpigmentationski
n lesions that followed theBlashko’s lines, 
and that spread throughout the body (Figure 
1). 
In about 70-80% of cases, extra-
cutaneous manifestations may occur. These 
include: dental abnormalities, that may be 
present in more than 80% of cases, as 
partial or total anodontia, conical teeth and 
tooth eruption delay; scarring alopecia in 
the scalp; nail dystrophy (7-40%) and 
ophthalmological manifestations 
(30%),which are the most serious and are 
usually associated with some neurological 
impairment
6
, including seizures, spastic 
paralysis, motor retardation and 
microcephalus
5
. Strabismus, nystagmus, 
cataract and optic nerve atrophy may occur. 
The retinal lesions are the result of vaso-
occlusive events
5
. The child showed no 
such dental or ocular changes related to the 
syndrome, but the ectasia of the ventricules 
is an unusual sign resulted from the 
neurological involvement
6
.Both findings 
must befollowed up by the appropriate 
specialties. 
As much as this syndrome affects 
multiple organs and systems, the 
association with an endocrine disorder is 
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not common. The authors of this article 
searched in SciELO and Medline databases 
publications about this association, but no 
articles were found. This was again 
confirmed by a contact made with the 
Brazilian Society of Dermatology, which 
denied having scientific material that relates 
this syndrome to some endocrine disorder. 
In the presentedcase, the child 
began to show clinical signs of precocious 
puberty at the age of three months, being 
observed by the mammary gland 
development, a fact that could be 
physiological, however, the bone age 
progression warned for the possibility of 
pathological PP. According to the literature, 
in girls, the development of the breast tissue 
and increased growth rate are the initial 
events of PP, under the influence of 
estradiol; while in boys, the increase in 
testicular volume> 4 ml or penis size> 2.5 
cm are the first clinical manifestations of 
puberty
2
. 
The diagnosis is confirmed by 
clinical findings, including the 
Tanner’sstages and growth spurt, 
accelerated bone maturation, the GnRH 
stimulation test results and, in girls, the 
evaluation of uterine and ovarian volume in 
the pelvic ultrasonography
2
. The child's 
classification M1 P2 at Tanner’s stages 
confirmed the beginning of puberty. 
Besides, the discrepancy between bone age 
(BA) and chronological age (CA), analyzed 
by the left hand and wrist X-ray according 
to Greulich– Pyle’s methods, showed an 
acceleration of the child's growth, and loss 
of  target height in case the treatment 
wasn’t promptly started. 
Pelvic ultrasound in girls helps the 
evaluation of uterine and ovarian volumes, 
besides allowing the analysis of cystsand 
neoplasia as differential diagnosis of 
precocious puberty³. As this examination 
was normal in the children, as there was no 
history of use of external steroids, the 
possibility of precocious puberty of 
peripheral originwas dismissed. The central 
origin of the disease was again confirmed in 
the GnRH stimulation test. According to the 
most sensitive laboratory methods, basal 
LH value > 0.6 U/L (immunofluorometric 
method) or> 0.2 U/L (chemiluminescence 
method) in both genders is considered 
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pubertal
3,10,11
. As the child presented with 
LH peak of 13.3 U/L, it was possible to 
confirm the diagnosis of puberty. 
Treatment with GnRH analogs 
(aGnRH) is indicated when the central PP is 
progressive. The goals of treatment are:to 
stop sexual development until the normal 
age of puberty onset; to slow growth and 
skeletal maturation; to avoid emotional 
problems in children; to delay the onset of 
sexual activity; to prevent pregnancy; to 
reduce the risk of sexual abuse and to 
reduce the risk of breast cancer associated 
with early menarche. ManyaGnRH are 
available as depot such as leuprolide 
acetate, goserelin and triptorelin, among 
others, intramuscular, subcutaneous or 
transdermal implants. The most used is the 
leuprolide acetate. The appropriate dose for 
satisfactory pubertal blocking varies around 
3.75 to 7.5 mg every 28 days³. In this case, 
drug treatment with 3.75 mg of leuprolide 
acetate IM was enough to stop the child's 
growth. Ideal weight and height for age 
were reached, the target height was 
recovered and the bone age progression was 
stabilized. 
Considering that precocious 
puberty and the Bloch-Sulzberger 
Syndrome are rare diseases, the description 
of a case in which both are associated 
makes this publication an interesting one, 
even more by the fact that no articles were 
found to relate this syndrome to any other 
endocrinopathy. 
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